![]() |
|
|
Vol. 285, Issue 2, 716-723, May 1998
Cardiology Division, University of Utah Medical Center, Salt Lake City, Utah
| |
Abstract |
|---|
|
|
|---|
Angiotensin II (A-II) is known to potentiate ischemic dysfunction during ischemia, but the mechanisms involved are not completely established. We examined the effects of A-II on intracellular calcium concentration ([Ca++]i) and cell contracture caused by metabolic inhibition in isolated adult rabbit ventricular myocytes. [Ca++]i was assessed by flow cytometry, using the Ca++-sensitive fluorescent probe, fluo-3. After 90 min of exposure to 2 mM cyanide (CN) and 0 glucose, there was a significant increase in myocyte [Ca++]i. This increase was slightly augmented in the presence of 100 nM A-II. In the presence of partial Na+/K+ ATP pump inhibition ([K+]o = 0.8 mM), there was a more significant increase in [Ca++]i associated with exposure to CN+A-II vs. CN alone. Similar results were obtained with CN plus 2-deoxyglucose, and the effect of A-II was inhibited by 10 µM 5-(N-ethyl-N-isopropyl)amiloride. Myocytes exposed to 2 mM CN and 0 glucose gradually developed contracture over a 3-hr period. Addition of 100 nM A-II significantly (P < .01) enhanced loss of rod shape morphology during 3 hr of CN exposure. Partial inhibition of the Na+ pump by exposure to 0.8 mM K+ had no effect on myocyte survival in the absence of CN, but augmented the harmful effect of A-II on cell contracture caused by CN exposure. This effect of A-II was completely reversed by the addition of 1 mM amiloride, a Na+/H+ exchange inhibitor. We conclude that A-II directly enhances cell injury during CN exposure in isolated rabbit ventricular myocytes. We postulate that this effect of A-II is mediated by stimulation of Na+/H+ exchange with resultant increased [Na+]i and subsequent [Ca++]i loading, possibly via reverse Na+/Ca++ exchange.
| |
Introduction |
|---|
|
|
|---|
ACE
inhibitors have now been widely shown to be clinically beneficial in a
number of cardiac conditions, including patients with asymptomatic left
ventricular dysfunction following acute myocardial infarction (Pfeffer
et al., 1992
). It seems likely that a component of the
beneficial effects of ACE inhibitors on the myocardium are indirect,
resulting from the inhibition of the deleterious peripheral
vasoconstrictive effects of A-II, which increase afterload. However,
there is now mounting evidence that A-II may exert direct effects on
the myocardium.
Recent work from our laboratory (Ikenouchi et al., 1994
) has
demonstrated that A-II induces an intracellular alkalosis in adult
rabbit myocytes, and that this effect is a consequence of stimulation
of Na+/H+ exchange (Matsui et al.,
1995
). Intracellular acidification develops during ischemia/hypoxia,
and increased Na+ loading as a consequence of
Na+/H+ exchange appears causally related to
ischemic/hypoxic injury in association with Ca++ overload
(Tani and Neely, 1990
; Renlund et al., 1984
; Haigney et al., 1992
; Barry, 1991
). We suspected that A-II may
therefore directly enhance ischemic/hypoxic myocardial injury by
augmenting Na+ overloading (via increased
Na+/H+ exchange) which would then lead to
Ca++ overloading (via reverse sarcolemmal
Na+/Ca++ exchange). Our study was designed to
test this hypothesis, in resting isolated adult rabbit ventricular
myocytes. This preparation allows examination of the effects of A-II on
cell injury and [Ca++]i without the influence
of vascular effects, the positive inotropic effect of A-II which could
affect energy metabolism of myocytes or alterations in loading
conditions that might complicate interpretation of the results. We
demonstrate that A-II increases [Ca++]i and
enhances myocyte contracture caused by CN exposure. These effects are
augmented by partial inhibition of the Na+ pump and
reversed by Na+/H+ exchange inhibitors.
| |
Materials and Methods |
|---|
|
|
|---|
Myocyte preparation.
Adult rabbit ventricular myocyte
isolation was performed by a modification of previously reported method
(Ikenouchi et al., 1994
). Briefly, hearts were removed from
albino rabbits (2-3 kg) anesthetized with sodium pentobarbital (65 mg/kg, i.v.). The heart was immediately attached to an aortic cannula,
and continuous retrograde coronary artery perfusion at 37°C by a pump
(Masterflex, Cole-Parmer Instrument Co., Chicago, IL) was initiated at
a coronary perfusion pressure of 60 mm Hg. The heart was first perfused
with nominally Ca++-free modified MKRBB solution for 5 min,
immediately followed by 20 min of recirculating perfusion with the same
solutions containing 0.28 mg/ml collagenase (class II, Worthington
Biochemical, Freehold, NJ), 0.4 mg/ml hyaluronidase (type I-S, Sigma
Chemical Co., St. Louis, MO) and 50 µM CaCl2. The heart
was then detached from the cannula, and the left ventricle was minced
and transferred to a 50-ml conical tube with the same solution
containing 0.28 mg/ml collagenase, 2 mg/dl trypsin and 50 µM
Ca++ and incubated for 10 min for further digestion. The
minced tissues were continuously agitated by gassing the solution with
5% CO2 and 95% O2 to help release isolated
myocytes. The resulting suspension was transferred to another conical
tube with the same volume of the same cell isolation solution
containing 2.4 mg/dl of trypsin inhibitor (Sigma) and 12%
heat-inactivated fetal calf serum. The cell suspension solution was
centrifuged at 300 rpm for 5 min. The supernatant was discarded and
cells were resuspended in solution with higher Ca++
concentration and incubated 15 min in the CO2 incubator to
settle down cells. The same procedure was repeated twice to slowly
bring up Ca++ concentration (200 then 1000 µM). Calcium
step up solutions were made up from MKRBB with 2% albumin, 50 µM
CaCl2 and 1 mg/dl insulin mixed with the appropriate amount
of MEM (Gibco Laboratories, Grand Island, NY). The cells were then
suspended in MEM containing 2% albumin to decrease cell-to-cell
adherence.
Solutions. For flow cytometric analysis, a HEPES-buffered balanced salt solution was used containing (in mM): NaCl 126, KCl 4.4 or 0.8, CaCl2 1.08, MgCl2 0.5, HEPES 24 (pH 7.4, adjusted with NaOH) and glucose 5. For myocyte contracture experiments, bicarbonate-buffered Tyrode's solution equilibrated with 95% air-5% CO2 (pH 7.4, 37°C) was used containing (in mM): 126 NaCl, 4.4 KCl, 1.0 MgCl2, 0.9 CaCl2, 18 NaHCO3, 5 glucose. For experiments using low K+, 0.8 mM KCl was substituted for 4.4 mM KCl. For metabolic inhibition, 2 mM CN or 2 mM CN + 20 mM 2DG, was added to the above solutions and glucose was removed. pH was adjusted to 7.4 with HCl. To these solutions, one or more of the following were added to make the respective study solutions: A-II (100 nM), amiloride (1 mM), EIPA (10 µM) (Sigma). Amiloride and EIPA were first dissolved into DMSO before being added into solution. The final concentration of DMSO was always less than 0.5%.
Assessment of [Ca++]i.
Intracellular calcium measurements were made with the Ca++
sensitive fluorescent probe, fluo-3 (Molecular Probes, Eugene, OR), using a flow cytometer (FACScan, Becton-Dickenson). The cells were
exposed to 4 or 10 µM fluo-3 for 30 min at room temperature. After 30 to 60 min of wash, the cells from a dissociation were separated into
aliquots and exposed to their respective solutions for 90 min at
37°C. Propidium iodide (25 µM, Molecular Probes), was added just
before data acquisition. PI is an impermeant ion that is fluorescent
when bound to DNA, and is therefore a marker for nonviability. During
flow cytometry, the cells were exposed to an argon laser (flow cell
0.18 × 0.43 × 2.2 mm, excitation wavelength, 488 nm). Side
and forward scattering characteristics were used to separate individual
cells from cell clumps and debris. Approximately 104
myocytes were then analyzed for emission fluorescence intensity in each
sample over 1 to 5 min. Data were collected for emission intensity at
wavelengths of 530 nm for fluo-3 and 670 nm for PI and plotted
simultaneously. Only those cells with the lowest fluorescent intensity
at 670 nm (propidium iodide "negative" or viable cells) were
included in the comparative analysis of
[Ca++]i (fluo-3 fluorescent intensity, 530 nm). In most experiments, the fluo-3 fluorescence intensity was not
calibrated, but was recorded as arbitrary units above background
(unloaded cell) fluorescence intensity. In some experiments, calibrated
[Ca++]i values were measured by exposing
cells to 10 µM ionomycin in the presence of 10 mM MnCl2,
as recently described (Yao et al., 1997
). Average Fmax, or
Ca++-saturated fluorescence, was estimated as 5× FMn, and
average Fmin, fluorescence in the absence of Ca++, as 1/40
Fmax as described by Kao et al. (1989)
. Average
[Ca++]i was then calculated as
[Ca++]i = KD (F
Fmin/Fmax
F) using a value of 864 nM for
Kd (Merritt et al., 1990
), after all
F values were corrected for background fluorescence. Probenecid 0.5 mM
was present in loading, wash and protocol solutions to prevent loss of
fluo-3 via the anion transporter (DeVirgilio et al., 1988
).
Fluo-3 fluorescence is relatively insensitive to intracellular pH in
the range of 6.6 to 7.4 (Eberhard and Erne, 1989
; Kao et
al., 1989
).
Assessment of cell contracture. The severity of cell injury was assessed by microscopic examination of cell morphology. Cells were plated on coverslips with cell adhesive (Laminin, Sigma) and were incubated for about 1 hr in a CO2 incubator before experimental manipulation. On every coverslip, three small circled areas were marked, which allowed us to follow the same cells in the circles under the microscope periodically. To change media for metabolic inhibition, coverslips were taken out from petri dishes and then put into other petri dishes that contained a washing solution (substrate-free Tyrode's solution). Then coverslips were taken out from the petri dishes again and put into other petri dishes containing substrate-free Tyrode's solution with CN. During this procedure, most of the dead cells were washed away. Therefore, more than 95% of the cells attached to the coverslips at the start of metabolic inhibition had a rod-shaped morphology. The dishes containing cells were placed in a CO2 incubator at 37°C during metabolic inhibition and taken out of the incubator briefly for counting rod-shaped cell number every 30 min. Cells were classified as either rod-shaped cells (length/width >3), or contracted cells (length/width <3). Loss of normal rod shape morphology was used as an index of myocyte injury.
Measurement of the degree of inhibition of Na/Ca exchange.
The exchange current was measured by means of a whole-cell voltage
clamp technique (Chin et al., 1993
). Myocytes were voltage clamped with single suction pipettes and a discontinuous voltage clamp
circuit (Axopatch 200A, Axon Instruments Inc., Foster City, CA).
Pipettes were made from borosilicate glass tubing (Corning 7052, 1.65 mm o.d., 1.2 mm i.d., A-M Systems Inc., Everett, WA) and had initial
resistances of 1.5 to 3 M
. The cells were held at a potential of
40 mV. The pipette contained (mM) NaCl 20, MgCl2 0.3, EGTA 14.0, MgATP 3.0, dextrose 5.5 and HEPES 10. Calcium (3.9 mM) was
added as H2CaEGTA. The free Ca++ was estimated
to be 100 nM. The solution pH was adjusted to 7.1 with CsOH. CsCl was
added to give a final Cs+ concentration of 130 mM.
Voltage-clamped cells were superfused in a microstream containing (mM)
NaCl 138.0, MgCl2 1.0, CaCl2 1.0, dextrose 11.0 and HEPES 12. The pH was adjusted to 7.4 with NaOH which gives a final
Na+ concentration of 145 mM. Outward exchange current was
activated when the cell was abruptly exposed to an adjacent microstream of solution in which Li+ replaced Na+. These
rapid solution changes were accomplished with a modified version of the
switching device whose characteristics and design have previously been
described (Yao et al., 1997
). For these experiments the two
adjacent microstreams simultaneously flowed from two square glass tubes
(200 µm) separated by a 70-µm glass septum. Currents were measured
in the presence and absence of amiloride 1 mM, and EIPA 10 µM.
Statistical analysis. All values are expressed as means ± S.E.M. A paired t test was used to assess significance between the intervention groups. For contracture studies, the test was performed at the last time point. Thus there was no need to adjust for multiple comparisons, because only one time point was used.
| |
Results |
|---|
|
|
|---|
Flow cytometry analysis of [Ca++]i and viability. Use of flow cytometry for measurement of [Ca++]i and viability in adult ventricular myocytes has not been previously reported. We therefore devoted some effort to the validation of these measurements. PI proved to be a reliable marker for cell viability. In preliminary experiments with an epifluorescence microscope, we observed that essentially all freshly dissociated rod-shaped cells excluded PI, and all "balled up" cells showed PI fluorescence. As shown in figure 1, we demonstrated a very good correlation between percent PI negative cells assessed by flow cytometry, and the percent rod-shaped (presumably viable) myocytes by manual microscopic count of freshly dissociated cells from nine different dissociations.
|
|
|
Effects of A-II and partial inhibition of the Na pump on fluo-3
fluorescence during CN exposure.
We next examined whether
stimulation of Na+/H+ exchange by A-II might
increase cytosolic calcium during CN exposure in adult rabbit
ventricular myocytes. Na+ pump function is impaired in
intact myocardium during ischemia, and impairment of the
Na+ pump might be expected to enhance any effect of
stimulation of Na+/H+ exchange by causing a
resultant greater increase in intracellular Na, and therefore more
marked alteration of Na+/Ca++ exchange.
However, in isolated myocytes, exposure to CN does not rapidly or
completely inhibit the Na pump (Hasin and Barry, 1984
). Therefore, we
investigated the effects of partial inhibition of the Na+
pump. In preliminary experiments, we used voltage clamp techniques (Shattock and Matsuura, 1993
) to quantitate the Na+ pump
current. We found that exposure to Ko+ = 0.8 mM
decreased the pump current by approximately 50%. Figure 4 shows an example of the effects of
exposure to CN on fluo-3 fluorescence in the presence of a normal (4.4 nM) Ko+ and in the presence of impaired function of the
Na+ pump produced by 0.8 mM Ko+. A-II
induced a slight increase in fluo-3 fluorescence during CN exposure.
Exposure to 0.8 mM K caused a slight increase in resting fluo-3
fluorescence and exacerbated both the rise in fluo-3 fluorescence
caused by CN exposure, and the increment in this increase associated
with simultaneous exposure to 100 mM A-II. Figure
5A shows normalized average values from
eight experiments. Exposure to A-II caused a statistically significant
increase in fluo-3 fluorescence in myocytes inhibited in the presence
of partial inhibition of the Na+ pump. As shown in figure
5B, average cell viability was not affected by MI, or MI plus A-II in
the presence or absence of partial pump inhibition.
|
|
|
Effects of A-II on cell contracture caused by metabolic inhibition
exposure.
To determine if effects of A-II during metabolic
inhibition are of physiological significance, we examined alterations
in cell morphology. Figure 7A shows the
effects of A-II on loss of rod shape morphology during CN exposure in
the presence of normal extracellular K+
([K+]o = 4.4 mM). Cells were exposed to
substrate free Tyrode's solution containing 2 mM CN in the presence or
absence of 100 nM A-II. During CN exposure, rod-shaped cells were
gradually decreased in number over a 3-hr period. A-II significantly
enhanced loss of rod shape morphology during CN exposure, but the
difference was small. As discussed, it appears that the Na+
pump can function in cardiac myocytes quite well when glycolysis is not
inhibited (Hasin and Barry, 1984
). We therefore also examined the
effects of partial inhibition of the Na+ pump by exposure
to low [K+]o on cell morphology under these
conditions. Figure 7B shows effects of low
[K+]o (0.8 mM) in the presence or absence of
100 nM A-II on cell morphology. These quiescent cells could tolerate
exposure to 0.8 mM [K+]o and retained rod
shape morphology under these conditions for more than 3 hr. In this
experiment, in the presence of low K+, A-II more markedly
enhanced cell contracture, assessed by loss of rod shape morphology,
during CN exposure. To examine if the enhanced cell contracture caused
by A-II is mediated by stimulation of Na+/H+
exchange, the effect of a Na+/H+ inhibitor was
examined. As shown in figure 7C, 1 mM amiloride completely abolished
the effects of A-II. We have previously shown that amiloride and EIPA
have similar inhibitory effects on Na+/H+
exchange in these cells (Matsui et al., 1995
). Comparison
with the effects of amiloride in the absence of A-II during CN exposure (fig. 7D) indicated that A-II has little effect on cell morphology in
the presence of amiloride during Na+/H+
exchange inhibition. Inhibitors of Na/H exchange may also inhibit Na/Ca
exchange (Kleyman and Cragoe, 1988
). To investigate whether any of the
effects of amiloride and EIPA noted in our experiments could be due to
inhibition of Na+/Ca++ exchange, we examined
their effects on the Na+/Ca++ exchange current
magnitude in adult rabbit ventricular myocytes. The control
INa/Ca was 0.82 ± 0.04 pA/pF; in EIPA (10 µm) it
was 0.83 ± 0.07; and in amiloride (1 mM) it was 0.58 ± 0.05 (means ± S.E.M., n = 5 to 12). Thus, the 28%
inhibition of Na/Ca exchange induced by the concentration of amiloride
we have used could have contributed in part to its effects on
contracture, but inhibition of Na/Ca exchanger does not contribute to
the effects of EIPA on changes in [Ca++]i
during metabolic inhibition. Taken together, these results suggest that
the augmentation of cell contracture caused by A-II is mediated by
stimulation of Na+/H+ exchange, and that an
increase in [Ca++]i resulting from altered
Na+/Ca++ exchange may be involved.
|
| |
Discussion |
|---|
|
|
|---|
Possible importance of direct effects of A-II on myocardial
ischemic injury/dysfunction.
A number of studies have demonstrated
that angiotensin converting enzyme inhibitors can have a beneficial
effect in patients with ischemic heart disease (see Lonn et
al., 1994
for review). Although a decrease in afterload seems
likely to account for a component of the benefit of ACE inhibition, it
has been recognized because the work of Koch-Weser (1964)
that A-II can
have direct myocardial effects. More recent studies (see Lindpaintner
and Ganten, 1991
) have also demonstrated that A-II may be produced directly within the myocardium by a local renin-angiotensin system. Thus some of the beneficial effects of converting enzyme inhibition in
the presence of myocardial ischemia could be due to a decrease in a
direct effect of circulating and/or locally produced A-II on the
cardiac myocyte.
Importance of Na+/H+ in ischemic
injury/dysfunction.
Murphy et al. (1991)
have
demonstrated in an MRI study that the Na+/H+
exchange inhibitor amiloride reduced the rise in intracellular Na+ during global ischemia in the rat heart, and markedly
delayed the increase in cytosolic calcium. Amiloride also decreased the rise in resting tension as estimated by isovolumic left ventricular diastolic pressure during ischemia, but had no effect on the rate or
extent of ATP depletion, or intracellular pH. This important observation has resulted in additional studies that have confirmed beneficial effects of Na+/H+ exchange
inhibitors on ventricular contractile function (Moffat and Karmazyn,
1993
), and electrophysiologic stability (Scholz et al.,
1992
) during ischemia. Recent work has suggested that a reduction in
Ca++ overload of blood perfused hearts might be responsible
for the beneficial effects of Na+/H+ exchange
inhibition on post ischemic function (Hendrikx et al., 1994
). It has also been shown that protein kinase-C activation aggravates hypoxic myocardial entry by stimulating
Na+/H+ exchange (Ikeda et al.,
1988
).
Possible mechanisms of A-II effects during metabolic
inhibition.
Recent work from our laboratory (Ikenouchi et
al., 1994
; Matsui et al., 1995
; Kohmoto et
al., 1993
; Ito et al., 1997
) has demonstrated that A-II
stimulates Na+/H+ exchange in adult rabbit and
rat ventricular myocytes, and induces an intracellular alkalosis. This
effect appears to be mediated by activation of protein kinase C
(Kohmoto et al., 1993
). Thus, it seemed possible that A-II
might exacerbate ischemic injury/dysfunction via a PKC-mediated
stimulation of Na+/H+ exchange.
Relevance of these findings to other species.
The extent to
which these findings can be extrapolated to species other than the
rabbit is uncertain at this point. Ishihata and Endoh (1995)
have
emphasized the species-related differences in inotropic effects of A-II
in mammalian ventricular muscle. Dog, rat and ferret myocardium was
less sensitive to the effects of A-II than rabbit. Moravec et
al. (1990)
have reported that A-II has positive inotropic effects
in human myocardium, both atrium and ventricle, whereas Lefroy et
al. (1996)
have reported that A-II has no effect on contraction of
isolated myocytes from guinea pig, rat and human ventricle, and from
human atrium. Holubarsch et al. (1993)
have reported that
A-II has inotropic effects in atrial but not ventricular human
myocardium. In addition, work from our laboratory has emphasized that
the effects of A-II on myocardial cells may vary with development
(Kohmoto et al., 1993
) and hypertrophy (Ito et
al., 1997
). Thus the extent to which our findings can be related
to beneficial effects of angiotensin converting enzyme inhibition in a
clinical situation where both acute and chronic myocardial effects can
be expected is uncertain.
Usefulness of flow cytometry for measurement of
[Ca++]i and viability in adult ventricular
myocytes.
To our knowledge, this is the first report that has
described the application of flow cytometry for the measurement of
changes in cytosolic Ca++ and viability simultaneously in
adult ventricular myocytes. Flow cytometry, of course, has been widely
applied for the measurement of a variety of fluorescent-based
parameters in nonmyocyte cells, but the large size and partial
viability of acutely dissociated adult ventricular myocytes has
complicated the methodology. By the use of PI and fluo-3 we were
clearly able to separate viable (non-PI staining) cells from nonviable
cells, and to measure cytosolic Ca++ in resting myocytes.
This approach allows the detection of alterations in Ca++
during metabolic inhibition induced by drugs, and extends previously reported use of flow cytometric analysis to study microtubular fluorescence in cardiac myocytes (Armstrong and Ganote, 1992
). This
promises to be a powerful technique that will facilitate the detection
of subtle changes in cytosolic Ca++ in large numbers of
viable isolated myocytes.
| |
Footnotes |
|---|
Accepted for publication January 14, 1998.
Received for publication March 11, 1997.
1 This work was supported by National Institutes of Health Grant HL-30478, and a Grant from Merck & Co., West Point, PA.
Send reprint requests to: Dr. William H. Barry, Cardiology Division, University of Utah Medical Center, 50 North Medical Drive, Salt Lake City, UT 84132.
| |
Abbreviations |
|---|
A-II, angiotensin II;
CN, cyanide;
2DG, 2-deoxyglucose;
EIPA, 5-(N-ethyl-N-isopropyl) amiloride;
ACE, angiotensin converting enzyme;
MKRBB, modified Krebs-Ringer bicarbonate
buffer;
MEM, minimum essential medium;
HEPES, [4-(2-hydroxyethyl)-1-piperazineethane-sulfonic acid;
DMSO, dimethyl
sulfoxide;
PI, propidium iodide;
EGTA, ethylene glycol-bis
(
-aminoethyl ether)-N,N,N1,N1-tetraacetic
acid.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Xu and T. L. Krukoff Adrenomedullin Stimulates Nitric Oxide Release from SK-N-SH Human Neuroblastoma Cells by Modulating Intracellular Calcium Mobilization Endocrinology, May 1, 2005; 146(5): 2295 - 2305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y.H. Woo, C. H.K. Cheng, and M. M.Y. Waye Baicalein protects rat cardiomyocytes from hypoxia/reoxygenation damage via a prooxidant mechanism Cardiovasc Res, January 1, 2005; 65(1): 244 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugishita, Z. Su, F. Li, K. D. Philipson, and W. H. Barry Gender Influences [Ca2+]i During Metabolic Inhibition in Myocytes Overexpressing the Na+-Ca2+ Exchanger Circulation, October 23, 2001; 104(17): 2101 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Senzaki, N. Paolocci, Y. A. Gluzband, M. L. Lindsey, J. S. Janicki, M. T. Crow, and D. A. Kass {beta}-Blockade Prevents Sustained Metalloproteinase Activation and Diastolic Stiffening Induced by Angiotensin II Combined With Evolving Cardiac Dysfunction Circ. Res., April 14, 2000; 86(7): 807 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||